About SpaceGen

Granted a U.S. invention patent——“Library construction method for detecting endometrial cancer-related gene mutations based on high-throughput sequencing”(Patent No. : US 12,553,152 B2)

Signed a strategic cooperation agreement with Autobio Biological to establish a comprehensive cooperation framework

The industry standard "Gene mutation in tumor tissue detection kit(high-throughput sequeneing)", which was drafted with our participation, has officially been implemented

The quality system has obtained the internationally authoritative certification from CAP in the United States

The quality system of SpaceGen Medical Laboratory obtained the internationally authoritative certification from CAP in the United States

The wholly-owned subsidiary, Suzhou SpaceSeq MedLab Co., Ltd.，a third-party medical laboratory, was established and obtained a medical institution practice license

9 products obtained the EU CE-IVD certification

"Human K-ras Gene Mutation Detection Kit (Multiplex Fluorescence PCR)" was approved for marketing by the National Medical Products Administration

Completed another financing of nearly 100 million yuan

Establishment of Suzhou SpaceSeq MedLab

Signed a strategic cooperation agreement with Guangzhou Wondfo Katis Biotechnology Co., Ltd

the "Oncology Multi-Gene Mutations Detection Kit " obtained the Class III Medical Device Registration Certificate from the National Medical Products Administration (NMPA)

Completed Series B financing of nearly 100 million yuan

Reached a strategic cooperation with Cygnus Biosciences (Beijing) Co., Ltd. and completed a C-round financing of hundreds of millions of yuan

the "Human EGFR Gene Mutation Detection Kit (Multiplex Fluorescence PCR Method)" obtained the Class III Medical Device Registration Certificate from the National Medical Products Administration (NMPA)

Signed strategic cooperation agreements with Agena Bioscience ("Agena") from the United States and Guangzhou Darui Biotechnology Co., Ltd

6 products obtained CE-IVD certification

The invention patent for RingCap®, a proprietary link amplification technology, was authorized by the China National Intellectual Property Administration

Won the title of "Double Hundred Plan" Leading Entrepreneurial Talent Settled Enterprise in Xiamen

Obtain CE-IVD certification for 5 products in the European Union

Obtained national and municipal high-tech enterprise certificates

Passed the German TUV ISO13485 medical device quality management system certification

Obtained nearly 40 million yuan in financing co-participated by Jingxu Venture Capital, Jingyuan Lanhai, and Dongfang Yirui

The core product obtained special approval from the National Medical Device Innovation Fund

Angel round - Qiao Jing Capital invested tens of millions

Pre-A: Completed a tens of millions strategic investment with Darui Biotech

The self-developed library kit for gene sequencing passed the certification of the Food and Drug Administration and obtained a Class I medical device registration certificate

Company establishment